She is able to stretch out her fingers and form a fist, something that took her almost two years to do the first time.
My Dad is doing well after completing his second month dose of NeuroAiD™. His memory is amazingly back, he can recall what he was doing before the stroke, he asks what happened to him, and how did he come from his village to the city. He recognises people and asks them relevant questions.
Florence Kata (Uganda)
Information for Medical Professionals
Learn key facts about NeuroAiD and assess how it can be relevant in your clinical practices
NeuroAiD™ is a trademark of Moleac. MLC601 (NeuroAiD™) and MLC901 (NeuroAiD™II / NurAiD™II) are 2 different proprietary formulae which have been shown to be equivalent in pharmacology and are referred as «NeuroAiD» on this page, except in case of specific mentions.